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Abstract
Rationale—Although use is prohibited, concerns remain for human exposure to nerve agents 
during decommissioning, research, and warfare. High-resolution mass spectrometry (HRMS) was 
compared to tandem mass spectrometry (MS/MS) analysis for the quantitation of five urinary 
metabolites specific to VX, Russian VX, soman, sarin and cyclosarin nerve agents. The HRMS 
method was further evaluated for qualitative screening of metabolites not included in the test 
panel.
Methods—Nerve agent metabolites were extracted from urine using solid phase extraction, 
separated using hydrophilic interaction chromatography and analyzed using both tandem and high 
resolution mass spectrometry. MS/MS results were obtained using selected reaction monitoring 
with unit resolution; HRMS results were obtained using a mass extraction window of 10 ppm at a 
mass resolution of 50,000. The benchtop Orbitrap HRMS instrument was operated in full scan 
mode, to measure the presence of unexpected agents.
Results—The assessment of two quality control samples demonstrated high accuracy 
(99.5-104%) and high precision (2-9%) for both HRMS and MS/MS. Sensitivity, as described by 
the limit of detection, was overlapping for both detectors (0.2-0.7 ng/mL). Additionally, the 
HRMS method positively confirmed the presence of a nerve agent metabolite, not included in the 
test panel, using the accurate mass and relative retention time.
Conclusions—The precision, accuracy, and sensitivity were comparable between the current 
MS/MS method and this newly developed HRMS analysis for five nerve agent metabolites. 
HRMS showed additional capabilities beyond the current method by confirming the presence of a 
metabolite not included in the test panel.
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Introduction
Nerve agents have been created and stockpiled for warfare purposes since their discovery in 
the 1930s. Although use of these compounds in recent warfare has been limited and is 
discouraged by the Chemical Weapons Convention [1], concerns remain that nerve agents 
will be used for non-sanctioned warfare or terrorist activities. Stockpiles throughout the 
world are gradually being decommissioned [1] and further laboratory research to improve 
treatments is being pursued [2, 3]. These activities may result in human contact with nerve 
agents; therefore, the continued ability to assess human exposure to nerve agents is needed.
The most common mass spectrometric approach for determining exposure to these specific 
compounds measures urinary nerve agent metabolites, which are hydrolysis products of the 
parent compounds [4-10]. Separation, identification and quantitation of these compounds 
has been reported using gas chromatography coupled with tandem mass spectrometry (GC-
MS/MS), and GC coupled with single quadrupole mass spectrometry (GC/MS) [6,11]. 
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has also been 
used with either hydrophilic interaction liquid chromatography (HILIC) [7,8] or anion 
exchange chromatography [9]. All of these methods measured multiple nerve agent 
metabolites in urine at part per billion (ppb) to part per million (ppm) levels.
The majority of mass spectrometric methods used to identify exposure are targeted analyses, 
detecting only specific nerve agent metabolites. While this approach is selective and often 
sensitive, only compounds included in the method will be identified. Exposure assessment to 
sarin (GB), soman (GD), cyclosarin (GF), VX, and Russian VX (rVX) is common [7-9], but 
other nerve agent metabolites may be excluded, such as the metabolite from the nerve agent 
tabun (GA). As exposure symptoms are not specific to individual nerve agents, screening for 
metabolites not included in the quantitative panel may be needed to confirm nerve agent 
exposure. One such qualitative screen for nerve agent metabolites in urine has been reported 
using high resolution mass spectrometry [12].
With the advent of bench top HRMS instruments, cost is no longer prohibitive for the 
acquisition of this technology [13]; hence, many comparisons of MS/MS and HRMS have 
recently been reported in the literature [14-19]. The results indicated that the tandem MS and 
HRMS analyses were very comparable [14]. HRMS methods have been able to match the 
validation acceptance criteria for accuracy, precision, selectivity, sensitivity and matrix 
effects previously established using LC/MS/MS [17]. Not only can HRMS be used to 
quantitate using reference materials, it has also been reported to qualitatively screen for 
compounds without the use of reference materials. The confirmation of the presence of these 
unknowns was based on exact mass plus characteristic fragments [20] or based on search 
criteria including a specific elemental composition coupled with a mass confidence level of 
95% [12].
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This study compared the precision, accuracy, sensitivity and specificity of ion trap HRMS to 
quadrupole tandem MS for the analysis of five nerve agent metabolites in urine. A nerve 
agent metabolite, not included in the standard solution, was evaluated to qualitatively 
confirm the presence of this compound in urine using HRMS.
Experimental
Materials
Solvents used included HPLC-grade methanol and HPLC-grade acetonitrile, both purchased 
from Fisher Scientific (Pittsburgh, PA). Deionized water used was obtained from an in-
house water purifier by Aqua Solutions (Jasper, GA). Ammonium acetate at 5M 
concentration was purchased from EMD Biosciences (LaJolla, CA). The following solutions 
were prepared volumetrically with Class I glassware and used for the extraction process: 
90% acetonitrile/10% water; 75% acetonitrile/25% water and 95% acetonitrile/5% water. 
Mobile phase was prepared by mixing 86% acetonitrile with 14% 20 mM ammonium 
acetate prepared in DI water.
Calibrators and quality control samples were prepared by Cerilliant (Round Rock, TX) in 
synthetic urine containing the following compounds: VX acid, ethyl methylphosphonic acid; 
GB acid, isopropyl methylphosphonic acid; GD acid, pinacolyl methylphosphonic acid; GF 
Acid, cyclohexyl methylphosphonic acid, and rVX acid, 2-(methyl) propyl 
methylphosphonic acid. Structures are presented in Figure 1. The concentrations of the 
calibrators were 1, 2, 5, 10, 25, 50, 100 and 200 ng/mL. The quality control sample 
concentrations were 15 and 75 ng/mL and a blank quality control sample was also included. 
Proficiency testing materials were provided by O2Si (Charleston, SC) in pooled urine. 
Individual urine samples and pooled urine were purchased from Tennessee Blood Services 
(Memphis, TN).
Internal standard was also provided at a concentration of 500 ng/mL prepared in water 
containing the following compounds: ethyl-D5 methylphosphonic acid; isopropyl-13C3 
methylphosphonic acid; pinacolyl (trimethylpropyl-13C6) methylphosphonic acid; 
cyclohexyl-13C6 methylphosphonic acid; and 2-(methyl)propyl (methylphosphonyl-13C, D3) 
methylphosphonic acid.
N,N-dimethylethylphosphoramidic acid (GA acid) was purchased from Los Alamos 
National Laboratory (Los Alamos, NM). A stock solution was prepared by the dilution of 
1.6 mg of GA acid into 1.6 mL of methanol. This solution was diluted into pooled urine, 
creating spiked matrix samples at the following concentrations: 100, 25 and 5 ng/mL. All 
calibrators and solutions were stored at −70 °C prior to use.
Sample preparation
Urine samples were diluted in acetonitrile and separated using solid phase extraction. One 
hundred microliters of urine sample or calibrator was added to 25 μL of isotopically labeled 
internal standard in a 2-mL 96 well plate. This mixture was placed on a Caliper i1000 
Sciclone (Hopkington, MA) for automated extraction. The i1000 incorporated positive 
pressure and evaluated the SPE plate following solvent addition for residual solvent, 
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ensuring that each SPE well had been evacuated before continuing to the next step. A Strata 
Si 96-well plate SPE by Phenomenex (Torrance, CA) with a 100 mg bed of 55 μm particle 
size SPE sorbent was conditioned by the i1000 with 1 mL of 75% acetonitrile/25% water 
followed by a second conditioning step of 1 mL of acetonitrile. The sample mixture was 
then diluted with 1000 μL of acetonitrile and mixed by drawing up the sample three times 
into the pipette tips. This mixture was loaded onto the conditioned SPE plate. The impurities 
were eluted from the SPE with two wash steps: 1) 1 mL acetonitrile and 2) 1 mL of 90% 
acetonitrile/10% water. Following the wash steps, a fresh 2-mL 96-well plate was placed 
under the SPE plate to receive the eluted sample. The cleaned sample was eluted with 1 mL 
of 75% acetonitrile/25% water from the SPE plate. The sample plate was then placed in a 
Biotage 96-Well Turbovap for concentration at 70 °C; the nitrogen flow was started at a low 
flow of ~15 standard cubic feet per hour and gradually increased to 70 standard cubic feet 
per hour to facilitate the dry down process without causing well-to-well contamination. The 
dried extracts were reconstituted using 100 μL of 95% acetonitrile/5% water and vortexed to 
mix using a plate vortexer (Wellmix, Thermo Labsystems, Waltham, MA). The 
reconstituted samples were then transferred to a 300 μL well plate and sealed using heated 
foil (Thermo Scientific, Waltham, MA) in preparation for chromatographic separation.
Instrumental analysis-Tandem MS
The reconstituted samples were injected onto the LC system consisting of two 1100 LC 
pumps, two degassers, a 10-port switching valve, column oven and autosampler by Aglient 
(San Jose, CA). The isocratic mobile phase was 84% acetonitrile mixed with 16% 20 mM 
ammonium acetate. A column flow rate of 500 μL/min with a ramp in flow rate to 1000 
μL/min was used to clear the column following the elution of the compounds. The HILIC 
column was a 2.1 × 50 mm Waters HILIC column with a 3 μm particle size maintained at a 
temperature of 40 °C. A 5 μL injection volume was used, which was lower than the 
previously published method using this sample preparation protocol [7] due to the 
translation from an AB Sciex 4000 MS/MS to an AB Sciex 5500 MS/MS.
The analytes were eluted into the AB Sciex 5500 tandem mass spectrometer (Framingham, 
MA) and ionized using negative electrospray ionization. Each compound was identified 
using multiple reaction monitoring (MRM) mass spectrometry, with the following 
parameters independently optimized: collision energy, declustering potential, cell exit 
potential and entrance potential. Two transitions per analyte were monitored to ensure 
specificity. Stable isotopically labeled internal standards were used to increase precision and 
accuracy by compensating for preparation losses and ionization suppression experienced by 
each analyte. The internal standards are identified by one MRM transition. Transitions are 
identified in Table 1.
Instrumental analysis-HRMS
The reconstituted samples were injected onto the LC system consisting of two LC pumps, 
degasser, column oven and autosampler by Shimadzu (Columbia, MD). The LC parameters 
were set the same as for the tandem MS analysis with the exception of a 35 μL injection 
volume. The analytes were eluted onto a Thermo Exactive (Waltham, MA) including a 
Heated Electrospray Ionization source (HESI-I) operated in negative ion mode. The heater 
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temperature for ionization was set at 300 °C, with sheath flow rate at 60 and auxillary flow 
rate at 20. The following voltages were used: spray voltage (4.5 eV), capillary voltage (−25 
eV), tube lens voltage (−70 eV), and skimmer voltage (−22 eV) as determined through 
infusion of least sensitive analyte with automated optimization. Automated gain control 
(AGC) set at Balanced (1 E6), with the maximum injection time at 100 ms. Resolution was 
maintained at high (50,000) throughout the study. The instrument was externally calibrated 
every three days as recommended by the manufacturer. Full scan data was captured for each 
run and a mass extraction window of 10 ppm around the calculated exact mass, presented in 
Table 1, was used for identification and quantitation of all compounds.
Quantitation
Quantitation was based on a standard curve comprised of eight calibrators ranging from 
1-200 ng/mL. The standard response was divided by the internal standard response to 
normalize any sample losses that occurred during preparation, separation and ionization. 
This value was charted against the known concentration of the calibrators. Each calibration 
curve must have attained a correlation coefficient of 0.990 or greater to be accepted. Quality 
was assured through the analysis of two positive quality control samples and one negative 
quality control sample. The positive quality control samples were characterized with a 
minimum of 20 independent analyses to determine the acceptable limits for each compound 
and level.
Sensitivity Comparison
The lowest reportable limit for this analysis was 1 ng/mL as defined by the lowest calibrator; 
the highest reportable limit was defined by the highest calibrator at a concentration of 200 
ng/mL. Limits of detection, used for comparison of sensitivity, were determined for all 
analytes using results obtained for the three lowest standards and the blank quality control 
sample. The standard deviation of twenty separate analyses of these standards was charted 
relative to the concentration and the y-intercept of the best fit line was multiplied by three as 
defined by Taylor [21]. This value was the estimated limit of detection used for this method 
comparison.
Results and Discussion
The HRMS ionization parameters were established through flow injection analysis of GB 
Acid, since this compound was the least sensitive in the initial evaluation. The following 
parameters, integral to ion formation, were optimized in this experiment: HESI heater 
temperature, sheath gas flow, aux gas flow, capillary temperature and spray voltage. To 
achieve the high sensitivity necessary, the settings that produced the largest number of ions 
in the mass spectrometer which still maintained accurate mass measurements were selected. 
This included the evaluation of the Automated Gain Control (AGC) at the three available 
settings: Ultimate (5e5), Balanced (1e6), High (3e6). The data obtained with both the High 
and Balanced AGC settings had the most peak intensity; however, the data obtained with the 
Ultimate AGC setting resulted in insufficient sensitivity. The Balanced AGC setting was 
selected since it was the ideal balance between sensitivity and mass accuracy. Resolution 
was also evaluated at following three settings: Enhanced (25,000 @ 4 Hz), High (50,000 @ 
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2 Hz) and Ultra High (100,000 @ 1 Hz). Complex matrices can result in unresolved 
interferences; therefore a minimum resolution of 25,000 is required, with a resolution of 
50,000 being ideal according to Kaufmann [15]. The resolution setting affects the speed of 
data collection and directly impacts the number of points across a peak, which is critical for 
quantitative analyses. As the typical peak for this analysis was approximately eight seconds 
wide, the High resolution setting was selected in order to acquire the best resolution data 
with more than ten points across each chromatographic peak.
Calibrators and quality control samples were prepared for analysis by both LC/MS/MS and 
LC/HRMS instruments. The chromatograms from both instruments are presented in Figure 
2. Twenty sets of calibrators with corresponding quality control samples were analyzed over 
a period of 43 days using both instruments and three analysts (Table 2). The resulting 
precision and accuracy of the quality control samples for both detectors demonstrates these 
methods to be within the specifications for bioanalyical methods as defined by the US Food 
and Drug Administration [23].
The high resolution mass spectrometric scan data was collected from 100 – 1500 m/z. It was 
noted that the scan range selection can significantly impact the accuracy of quantitative 
results obtained with this system. Since the instrument automatically scans from the start 
mass plus 15 times that mass, as indicated by the manufacturer, the selected scan range was 
not truncated. The automatic gain control, necessary for minimizing space-charge induced 
mass error [22], can negatively impact the number of desired ions filling the Orbitrap. If an 
undesired ion dictated the fill time, less of the desired ions would be included for 
measurement. An improvement in accuracy of 5-10% was observed for both GD Acid and 
GF Acid when the selected scan range excluded the abundant acetate ion (59 m/z). 
Additionally, the linearity of the analysis and the detection of the low calibrator, in 
particular for VX Acid and GB Acid, were also improved.
To ensure comparability between the instruments across the entire reportable range, nineteen 
pooled urine samples spiked with five nerve agent metabolites were prepared in triplicate 
and analyzed on both systems. The variability, as described by the relative standard 
deviation, did not exceed 13.4% for HRMS and 9.4% for MS/MS, indicating the 
reproducibility of both analytical methods within FDA specifications [23]. The results were 
compared to one another by the dividing the HRMS result by the MS/MS result and 
multiplying the resulting ratio by 100; a ratio of 100% indicates perfect reproducibility 
(Table 3). For all compounds the average ratio was within 90 – 110%, indicating high 
comparability between instruments.
The mass extraction window (MEW) was established during method development as 
recommended in the literature [24], to minimize potential interference while maintaining 
sufficient signal for this application. Xia, et al, incorporated a calculation to determine the 
maximum MEW required for a given mass as a function of the resolving power [24]. This 
approach was applied to all compounds included in this method; the calculated maximum 
MEW ranged from 15-18 ppm. Additionally, the required mass accuracy to result in a single 
elemental composition for each nerve agent metabolite was determined to be similar to 
previous studies [25]. This assessment resulted in 5-7 potential compounds within a 20 ppm 
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mass accuracy; however, with a mass accuracy of 10 ppm only a single elemental 
composition option remained for all compounds. Urine samples from persons with no 
exposure to nerve agents were evaluated for potentially interfering masses to the compounds 
of interest. No contributing species were detected at a MEW of 10 ppm for all five nerve 
agent metabolites. Given the lack of calculated and measured interferences for these 
compounds, the use of 10 ppm MEW was selected for quantitation in extracted urine.
Background response for the GB-Acid internal standard was observed to increase over time. 
Since a smaller MEW often minimizes interferences by eliminating adjacent masses, the 
results were assessed using a 7 ppm MEW (Figure 3), in addition to the established 10 ppm 
MEW. The internal standard background response was reduced with this selection; however, 
the evaluation of five calibration curves and quality control samples resulted in no 
improvement of precision or accuracy. Further investigation determined that the background 
response could be minimized with regular cleaning of the ion transfer tube.
It is essential in clinical samples to minimize false-positive results which may occur from 
unknown interferences. Seventy-two individual urine samples with no known exposure to 
nerve agents were spiked with internal standard, prepared as indicated above, and analyzed 
using both instruments. The detection of a peak in these urine samples would indicate the 
presence of an endogenous interference; the quantitation of an interference peak above the 
lowest standard would result in a measurable false positive. HRMS analysis identified no 
quantitative responses above the reportable limit for 72 individual urine samples. MS/MS 
analysis identified one quantitative response at 1 ng/mL for GB Acid, but no other peaks 
were detected above the reportable limit. Given this information, HRMS resulted in no false 
positives and MS/MS resulted in one false positive in 72 unexposed urine samples. It should 
be noted that even though different LC systems were used for this analysis, the retention as 
measured by the retention factor, k’, was the same on both systems, indicating that the 
differences were a result of the mass spectrometric detection, not the chromatographic 
separation.
Sensitivity, as defined by the estimated limit of detection (LOD), was calculated for all five 
analytes for both instruments and is presented in Table 4. All LODs were within the same 
order of magnitude. With little difference between the estimated LODs for MS/MS and 
HRMS results, the sensitivity of both detectors can be described as equivalent for this 
evaluation.
HRMS relied on the exact mass to identify each compound; therefore, mass accuracy was 
paramount. The mass accuracy was evaluated throughout the concentration range and did 
not deviate more than 6 ppm from the nominal value. This mass stability indicated that 
regardless of the concentration, the analyte of interest would be identified correctly and 
included in the mass extraction window.
Confirmation of the analyte measured is often achieved through the measurement of 
additional compound specific ions [25, 26]. The tandem MS method measured two separate 
product ions for each of the five nerve agent metabolites included in this panel; however, the 
HRMS method only measured the one ion per compound, and lacked the measurement of a 
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confirmation ion. An additional mass spectrometric period to measure confirmation ions will 
needed together with the procurement of different isotopically labeled internal standards. 
The currently available isotopically labeled internal standards form the same product ions as 
the native compounds, resulting in 95, 77 or 79 m/z, excepting RVX Acid.
The HRMS analysis has the added ability to screen for nerve agent metabolites or similar 
compounds not included in the current panel. GA acid was spiked into pooled urine at three 
concentrations of 100, 25, and 5 ng/mL. These samples were spiked with the internal 
standard mixture, extracted and analyzed in the same manner as indicated previously. The 
calculated exact mass for the ionized GA Acid, 152.0476 m/z, was extracted for all samples 
using a MEW of 10 ppm. The extracted chromatograms demonstrated an increase in signal 
corresponding to spike concentration (Figure 4). A unique product ion of 124.0460 m/z was 
also identified for this compound. Additional confirmation that this peak resulted from GA 
Acid was the relative retention time, which fell between GF Acid and GD Acid, correlating 
with previous studies [13].
Conclusions
The strength of HRMS method developed in this study is the ability to quantitate and screen 
for additional compounds in a single method. The high resolution mass spectrometer 
obtained comparable precision, accuracy, sensitivity and specificity to the tandem mass 
spectrometric method for the quantitation of five nerve agent metabolites resulting from 
exposure to sarin, soman, cyclosarin, VX and Russian VX. Furthermore, the HRMS was 
able to identify the presence of another nerve agent metabolite, not included in the standard 
panel, based upon accurate mass, specific product ion, and relative retention time. Search 
criteria reported elsewhere [12] may be applied using this instrumentation for the detection 
of other nerve agent metabolites in the event of a suspected exposure.
The tandem MS method excels at confirmation for this assay, as it meets the criteria for a 
confirmatory method [26]. Further adjustments to the HRMS method will be required for 
qualification as a confirmatory method, including the addition of another mass spectrometric 
period to measure confirmation ions and the synthesis of different isotopically labeled 
internal standards for four of the five compounds, which is cost prohibitive at this time.
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Figure 1. 
Structures of nerve agent metabolites and corresponding internal standards.
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Figure 2. 
Chromatograms for quality control sample (15 ng/mL) for both high resolution and tandem 
mass spectrometry
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Figure 3. 
Mass extraction window of 10 and 7 ppm for GB Acid internal standard (140.0469 m/z) in 
matrix
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Figure 4. 
Extracted urine spiked with GA Acid, mass extraction window of 10 ppm
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